Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31663413 | 1.00 | ERN1 (0.62) | ERN1MAPTCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL20357461 | 0.92 | ERN1 (0.55) | ERN1MAPTCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL547658 | 0.90 | HPRT1 (0.54) | ERN1MAPTCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL12426749 | 0.86 | ERN1 (0.52) | ERN1MAPTCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL7538398 | 0.86 | ERN1 (0.52) | ERN1MAPTCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3267811 | 0.86 | ERN1 (0.56) | ERN1MAPTCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3273911 | 0.83 | ERN1 (0.53) | ERN1MAPTCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3273913 | 0.83 | ERN1 (0.53) | ERN1MAPTCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL347177 | 0.82 | ERN1 (0.43) | ERN1MAPTCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL14149575 | 0.81 | ERN1 (0.47) | ERN1MAPTCYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 625 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119119822-A | Organic/inorganic hybrid high-refractive index carbonized polymer dot film layer and preparation method thereof | 吉林大学 | 2024-12-13 | — | — | CN | claimed |
| CN-118652463-A | Phosphorus-modified azole compound flame-retardant modified BOPET film and preparation method thereof | 康辉南通新材料科技有限公司 | 2024-09-17 | — | — | CN | claimed |
| CN-118324119-A | Petroleum asphalt-based high-crystallization soft carbon material and preparation method thereof | 大连理工大学 | 2024-07-12 | — | — | CN | claimed |
| CN-118325204-A | Low-temperature-rise rubber and carbon black composition and preparation method thereof | 华南理工大学 | 2024-07-12 | — | — | CN | claimed |
| CN-117645577-A | Circular polarization excimer luminescent molecule, luminescent material, preparation method and application thereof | 中国科学院化学研究所 | 2024-03-05 | — | — | CN | claimed |
| CN-116375716-A | Preparation method and application of cavern crown ether compound | 黄淮学院 | 2023-07-04 | — | — | CN | claimed |
| CN-115304726-A | Annular high polymer material and preparation method and application thereof | 湖南西林环保材料有限公司 | 2022-11-08 | — | — | CN | claimed |
| US-11382868-B2 | Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same | ICURE PHARMACEUTICAL INC. (KR) | 2022-07-12 | — | — | US | claimed |
| WO-2019164231-A1 | COMPOSITION FOR HARD MASK | 동우화인켐 주식회사 | 2019-08-29 | — | — | WO | claimed |
| US-20190046463-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | ICURE PHARMACEUTICAL INC. (KR) | 2019-02-14 | — | — | US | claimed |
| EP-1534413-B1 | DISPERSANT AND FOAMING AGENT COMBINATION | GEO SPECIALTY CHEMICALS INC (US) | 2014-12-03 | — | — | EP | claimed |
| US-8507896-B2 | Compounds having electroluminescent or electron transport properties | MERCK PATENT GMBH (DE) | 2013-08-13 | — | — | US | claimed |
| CN-101241104-B | Method for simultaneous determination for taurine, epsilon-amino caproic acid and L-aspartic acid content of medicament | UNIV SICHUAN | 2011-10-05 | — | — | CN | claimed |
| US-20110006295-A1 | COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES | MERCK PATENT GMBH | 2011-01-13 | — | — | US | claimed |
| CN-101241104-A | Method for simultaneous determination for taurine, epsilon-amino caproic acid and L-aspartic acid content of medicament | UNIV SICHUAN (CN) | 2008-08-13 | — | — | CN | claimed |
| US-20040205905-A1 | Dye composition for keratin fibers, comprising at least one compound chosen from ortho- and alpha-dialdehyde compounds and at least one sulphur compound | L'OREAL S.A. (FR) | 2004-10-21 | — | — | US | claimed |
| EP-1430878-A1 | Composition to dye keratinic fibres comprising at least one ortho- or alpha-dialdehyde and at least one sulphurous compound | L'OREAL (FR) | 2004-06-23 | — | — | EP | claimed |
| US-4380629-A | Styryl-like compounds showing a color-developing and bleaching behavior with improved stability and prolonged lifetime | MATSUSHITA ELECTRIC INDUSTRIAL COMPANY, LIMITED (JP) | 1983-04-19 | — | — | US | claimed |
| US-4279787-A | DIAGNOSTIC PRODUCTS | TETRA CONSULTANTS INC. (US) | 1981-07-21 | — | — | US | claimed |
| US-3950414-A | Preparation of aromatic diacid chlorides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-04-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110006295-A1 | COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES | NR2E3, NR4A2, NR4A3 | ERN1 2585/4885MAPT 3534/4885CYP1A2 544/4885 |
| US-20040205905-A1 | Dye composition for keratin fibers, comprising at least one compound chosen from ortho- and alpha-dialdehyde compounds and at least one sulphur compound | KRT18, DSP, DSG1 | ERN1 3182/4885MAPT 360/4885CYP1A2 2438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.